ULK1 and Stroke: Xiong et al. demonstrated that pharmacological activation of ULK1 using LYN-1604 significantly reduced infarct volume, improved behavioral outcomes, and promoted anti-inflammatory microglial/macrophage polarization in a photothrombotic stroke model [166].